Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Burr

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Plos One|August 17, 2018
PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosaLucy D Burr, Geraint B Rogers, Alice C-H Chen, et al.
Annals of the American Thoracic Society|July 28, 2016
Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study TrialLucy D Burr, Geraint B Rogers, Alice C-H Chen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 30, 2020
The cystic fibrosis gut as a potential source of multidrug resistant pathogensSteven L Taylor, Lex E X Leong, Sarah K Sims, et al.
Msphere|April 20, 2018
Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis BronchiectasisJocelyn M Choo, Guy C J Abell, Rachel Thomson, et al.
Gut Microbes|October 26, 2018
Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gutYanan Wang, Lex E X Leong, Rebecca L Keating, et al.
Microbiology Spectrum|June 22, 2023
The Impact of Long-Term Macrolide Exposure on the Gut Microbiome and Its Implications for Metabolic ControlJocelyn M Choo, Alyce M Martin, Steven L Taylor, et al.
The Journal of Experimental Medicine|September 11, 2023
Interleukin-22 suppresses major histocompatibility complex II in mucosal epithelial cellsMd Moniruzzaman, M Arifur Rahman, Ran Wang, et al.
Lung|November 7, 2019
Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?Simone K Visser, Peter T P Bye, Greg J Fox, et al.
Journal of Medical Virology|October 13, 2025
Vaccine-Induced and Hybrid Immunity Against SARS-CoV-2 Variants of Concern in Two Cohorts in Queensland, Australia (2021-2022)Rhys H Parry, Yingjun Shang, Julian D J Sng, et al.
Respiratory Medicine|July 22, 2019
Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis RegistrySimone K Visser, Peter T P Bye, Greg J Fox, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Plos One|August 17, 2018
PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosaLucy D Burr, Geraint B Rogers, Alice C-H Chen, et al.
Annals of the American Thoracic Society|July 28, 2016
Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study TrialLucy D Burr, Geraint B Rogers, Alice C-H Chen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 30, 2020
The cystic fibrosis gut as a potential source of multidrug resistant pathogensSteven L Taylor, Lex E X Leong, Sarah K Sims, et al.
Msphere|April 20, 2018
Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis BronchiectasisJocelyn M Choo, Guy C J Abell, Rachel Thomson, et al.
Gut Microbes|October 26, 2018
Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gutYanan Wang, Lex E X Leong, Rebecca L Keating, et al.
Microbiology Spectrum|June 22, 2023
The Impact of Long-Term Macrolide Exposure on the Gut Microbiome and Its Implications for Metabolic ControlJocelyn M Choo, Alyce M Martin, Steven L Taylor, et al.
The Journal of Experimental Medicine|September 11, 2023
Interleukin-22 suppresses major histocompatibility complex II in mucosal epithelial cellsMd Moniruzzaman, M Arifur Rahman, Ran Wang, et al.
Lung|November 7, 2019
Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?Simone K Visser, Peter T P Bye, Greg J Fox, et al.
Journal of Medical Virology|October 13, 2025
Vaccine-Induced and Hybrid Immunity Against SARS-CoV-2 Variants of Concern in Two Cohorts in Queensland, Australia (2021-2022)Rhys H Parry, Yingjun Shang, Julian D J Sng, et al.
Respiratory Medicine|July 22, 2019
Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis RegistrySimone K Visser, Peter T P Bye, Greg J Fox, et al.
Pageof 11